Literature DB >> 9278463

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

B Dawson-Hughes1, S S Harris, E A Krall, G E Dallal.   

Abstract

BACKGROUND: Inadequate dietary intake of calcium and vitamin D may contribute to the high prevalence of osteoporosis among older persons.
METHODS: We studied the effects of three years of dietary supplementation with calcium and vitamin D on bone mineral density, biochemical measures of bone metabolism, and the incidence of nonvertebral fractures in 176 men and 213 women 65 years of age or older who were living at home. They received either 500 mg of calcium plus 700 IU of vitamin D3 (cholecalciferol) per day or placebo. Bone mineral density was measured by dual-energy x-ray absorptiometry, blood and urine were analyzed every six months, and cases of nonvertebral fracture were ascertained by means of interviews and verified with use of hospital records.
RESULTS: The mean (+/-SD) changes in bone mineral density in the calcium-vitamin D and placebo groups were as follows: femoral neck, +0.50+/-4.80 and -0.70+/-5.03 percent, respectively (P=0.02); spine,+2.12+/-4.06 and +1.22+/-4.25 percent (P=0.04); and total body, +0.06+/-1.83 and -1.09+/-1.71 percent (P<0.001). The difference between the calcium-vitamin D and placebo groups was significant at all skeletal sites after one year, but it was significant only for total-body bone mineral density in the second and third years. Of 37 subjects who had nonvertebral fractures, 26 were in the placebo group and 11 were in the calcium-vitamin D group (P=0.02).
CONCLUSIONS: In men and women 65 years of age or older who are living in the community, dietary supplementation with calcium and vitamin D moderately reduced bone loss measured in the femoral neck, spine, and total body over the three-year study period and reduced the incidence of nonvertebral fractures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278463     DOI: 10.1056/NEJM199709043371003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  395 in total

Review 1.  Geriatric medicine.

Authors:  S E Straus
Journal:  BMJ       Date:  2001-01-13

2.  Dietary supplements and physical exercise affecting bone and body composition in frail elderly persons.

Authors:  N de Jong; M J Chin A Paw; L C de Groot; G J Hiddink; W A van Staveren
Journal:  Am J Public Health       Date:  2000-06       Impact factor: 9.308

3.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Authors:  E M Scott; I Gaywood; B B Scott
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 4.  Treatment induced changes of bone density and relative risk of vertebral fracture.

Authors:  S Adami; O Viapiana; F Corallo
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 5.  The role of SERMs in the management of postmenopausal osteoporosis.

Authors:  J Compston
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 6.  Treatment of postmenopausal osteoporosis: an evidence-based approach.

Authors:  C J Rosen
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

7.  Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?

Authors:  S Hathirat; M F Evans
Journal:  Can Fam Physician       Date:  2001-10       Impact factor: 3.275

Review 8.  Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis.

Authors:  S A Atkinson; W E Ward
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

9.  Bone densitometry is not a good predictor of hip fracture.

Authors:  T J Wilkin; D Devendra
Journal:  BMJ       Date:  2001-10-06

Review 10.  Using bone densitometry to monitor therapy in treating osteoporosis: pros and cons.

Authors:  C L Deal
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.